TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Incidence of liver function impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events incidence and severity
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacodynamic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OG catheter-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OG catheter-related comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: TWA of intraoperative hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of pre-SD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain score 5 minutes post-injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Success at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Repeatability of ArcScan Insight 100 zonule scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of ArcScan Insight 100 zonule scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of Mother's Own Milk (MoM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to ARI discontinuation (days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to progression to metastatic prostate cancer (mPC) (days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Meat consumption at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Meat consumption at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole body rate of appearance of lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HBeAg seroconversion to anti-Hbe
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IKDC Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: incidence of complications after splenectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with Treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percent change from Baseline in platelet count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent change from Baseline in serum lactate dehydrogenase (LDH) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decisional conflict regarding end-of-life care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wound Healing Index (WHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fertilization Rate (FR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Day 5 usable blastocyst rate (D5UBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Blastocyst quality grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of participants with treatment-emergent adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: registered radiation associated adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Platelet counts at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Occurrence of perioperative respiratory adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: IP Treatment Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels measured by STAI Anxiety Scale I
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Beta Coefficient from Linear Regression of Seizure Amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Compliance with ONS prescription
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Biodistribution of 18F-FDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathophysiology of 18F-FDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of acalabrutinib with R-CHOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of lung collapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Dyadic Adjustment from baseline to the end of the course
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Dyadic Adjustment from the end of the course to 6 months after the course
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FLAME global composite score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Microbial assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients with positive culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: prone position adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Knowledge about clitoris
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in CKD stage based on ICD codes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in KDIFO eGFR stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in cellular composition of carotid plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in Health Environment Rating Scale Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Devereux Early Childhood Assessments Scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Rate of improvement in adherence to survivorship plan
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rebleeding of esophageal varices within 5 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-employment rate
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Change in hs-CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral load change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total radioactivity recovery in urine and feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve [AUC] of baxdrostat and CIN-107M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration [Cmax] for baxdrostat and CIN-107M in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sonographic Proficiency Assessment Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and severity of treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants experiencing AE with abnormal laboratory values
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants experiencing AE with abnormal Electrocardiograph
Endpoint domain: Adverse events/effects
Primary endpoint: Referral rate to non-opioid care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Antidepressant orders
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Autoregulation of retinal blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Erectile dysfunction assessment using the International Index of Erectile Function questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Erectile dysfunction assessment using the Erectile Hardness Score questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change from baseline in metabolic health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in C-reactive protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Oxidative stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful Balloon Placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Successful Balloon Removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Response rate to targeted therapy based on molecular profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of non-invasive MRD assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of non-invasive MRD assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of Muscle fibers in the resected specimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability and usability of the app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Variation from baseline of morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and size of polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tolerability of R-3750
Endpoint domain: Adverse events/effects
Primary endpoint: first-attempt success rate of arterial catheterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HCV testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cognitive battery (RAVLT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cognitive battery (ROCF: Copy, immediate recall)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cognitive battery (Digit Symbol Coding, subscale of WAIS-PSI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cognitive battery (Digit Span: Digit backward (subscale of WAIS-WMI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cognitive battery (Trail Making Test, Part B)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in cognitive battery (ROCF: Delayed recall)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Postpartum maternal blood folate status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postpartum maternal blood DHA status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postpartum maternal blood vitamin B12 status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in dysmenorrhea severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in menstrual symptom scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biopsy-complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AHI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe stent removal
Endpoint domain: Adverse events/effects
Primary endpoint: Change in overall stability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in proportion of missed antiretroviral (ARV) doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in antiretroviral treatment (ART) adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of missed visits accrued
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in clinic visit adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Progression of axial length (AL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and progression of visual field (VF) defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Loss of best corrected visual acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Play Tendencies
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Social Problem Solving Level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Activity of the Abductor Hallucis Longus, Tibialis Anterior or Peroneus Longus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Chronicity of migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Paraspinal muscle quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Annular tear size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Disc degeneration grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Self-reported Physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: P200 amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative slow wave difference score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slow wave difference score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency to peak of P100
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in respectful maternity care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Adequate occlusion rate of aneurysms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in community reintegration level
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Amount of perioperative catecholamine usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of transfusion required
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of COVID-19 vaccination in cancer population
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hesitancy to COVID-19 vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3 stage balance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-second chair stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute necrotizing encephalitis severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Odds of symptomatic SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Positive seroprevalence of SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Parkinson's-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: skin thickness of the arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Development of malignancy
Endpoint domain: Mortality/survival
Primary endpoint: Immediate interference rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed interference rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post operative VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported knowledge awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in perception of home dialysis adoption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence of sPCa on prostate biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of men who avoid transperineal prostate biopsy in the experimental arm
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of participants answering post-test questions correctly
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Composite of Chorioamnionitis, Postpartum Endometritis, SSI, Wound Infection, or Other Post-cesarean Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Visual analogue scale (VAS) scores for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of supraventricular tachycardia (svT)/ventricular fibrillation (VF) episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: The recovery of menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Irradiation levels measured
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Types 2, 3, and 5 bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined major adverse cardiovascular and cerebrovascular events (MACCEs)
Endpoint domain: Mortality/survival
Primary endpoint: variations in AC signal of photoplethysmography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variations in DC signal of photoplethysmography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of GBT021601 in whole blood and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thrombus burden reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycaemic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local tolerability at pump injection site
Endpoint domain: Adverse events/effects
Primary endpoint: Atherosclerotic plaque progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Adverse events and serious adverse events deemed due to HIFU
Endpoint domain: Adverse events/effects
Primary endpoint: Number of resectable STS participants converted to unresectable by HIFU
Endpoint domain: Adverse events/effects
Primary endpoint: Number of limb salvageable STS participants converted to amputation by HIFU
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with intra-abdominal desmoid tumour requiring surgery due to complication
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Dronabinol-induced transcriptome profile in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Go/No-Go Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Serial 7s
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: TRIFECTA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the serum creatinine level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cognition Morning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognition Afternoon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: One-year disease-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Analgesic agent use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: looking time during natural social scenes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: looking time to social scenes presented on a screen
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in nasal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility assessed by percent enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety assessed using end of study survey
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Hope assessed using Herth Hope Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opioid pills prescribed by Campbell Clinic
Endpoint domain: Resource use
Endpoint subdomain: Other resource use